Nanopath

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. Nanopath is based in Cambridge, MA and was founded in 2019. It was valued at $32 million at its early-stage round in Aug 2022, the last priced event on record. It has raised $16.4 million across 2 recorded rounds; the latest was a $5.3 million debt round in Jan 2025.

PMV mark · valuation
$32.0M
Oct 2026
Priced at
its early-stage round
Aug 2022
Total raised
$16.4M
Last round
Debt
Jan 2025
How much has Nanopath raised?
$16.4Macross 2 recorded rounds · Jun 2022 – Jan 2025

Most recently, Nanopath raised $5.3M in its Debt (Jan 2025).

Free account
More of Nanopath with a free account
  • ·The complete investor list: 17 names
  • ·Watch Nanopath: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nanopath round by round

2 rounds
Jan 2025Debt$5.3MSEC filing▮
5 investors participated
Jun 2022Early Stage VC$10.0MSEC filing▮
10 investors participated

How much has Nanopath raised?

Nanopath has raised $16.4 million across 2 recorded rounds since 2022. The largest was a $5.3 million debt round in Jan 2025.

Nanopath has filed 2 Form Ds with the SEC since 2022, most recently in Feb 2025 ($5.3 million sold to 5 investors).

Nanopath investors

17 investors are on record for Nanopath, including Alumni Ventures, Creative Destruction Lab, US National Science Foundation and Service Provider Capital. By type, the record holds 4 venture capital firms and 1 family office. The debt round in Jan 2025 drew 5 investors.

For fundraisers
Raising for a company like Nanopath?

17 investors have backed Nanopath.

See all 17 investors →

Frequently asked about Nanopath

How much has Nanopath raised?
Nanopath has raised $16.4M in total across 2 recorded funding rounds.
When was Nanopath's last funding round?
Nanopath's most recent recorded round was Debt in Jan 2025, raising $5.3M.